Tagged: Pfizer/BioNTech vaccine

The cold supply chain can’t reach everywhere – that’s a big problem for equitable COVID-19 vaccination - COVID-19

Guest Author Jan 19, 2021

Timothy Ford, University of Massachusetts Lowell and Charles M. Schweik, University of Massachusetts Amherst To mitigate health inequities and promote social justice, coronavirus vaccines need to get to underserved populations and hard-to-reach communities. There are few places in the U.S. that are unreachable by road, but other factors – many rural hospitals can’t afford ultralow-temperature freezers or might … Read More

Those vaccine ingredients again - BioBlog

Alison Campbell Dec 11, 2020

A year ago I posted an explanation on vaccine “ingredients”, in relation to some wild claims made about the measles vaccine in the context of Samoa’s measles epidemic. From what I’ve seen on recent RNZ comments threads, an update for the time of SARS-Cov-2 is required. So, here’s purple making a statement about the Pfizer covid-19 vaccine that – … Read More

30% of New Zealanders are ‘vaccine sceptics’, so trust is key to COVID-19 vaccine roll-out - COVID-19

Guest Author Dec 11, 2020

Claire Breen, University of Waikato The emergency approval of the Pfizer/BioNTech COVID-19 vaccine in the UK and the imminent roll-out of several other vaccines in 2021 raises serious questions about New Zealand’s likely uptake of this vital public health response. Recent research into New Zealanders’ attitudes to vaccination suggest positions have become more polarised over the last decade, … Read More